HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

The 24% Rent Jump Inside Parkway Life REIT’s FY2025

Introduction In an era of global economic shifts and fluctuating market sentiment, healthcare real estate...
SGX-LISTED COMPANIES

Why The World’s Geriatric Fleet Is Nam Cheong’s Secret Weapon

Unlocking the OSV Cycle For more than a decade, the offshore support vessel (OSV) industry...
SGX-LISTED COMPANIES

Why This Tiny Lab Is Outpacing Global Giants

The $1.5 Trillion Green Transition’s Secret Weapon In the high-stakes theater of the modern economy,...
SGX-LISTED COMPANIES

How GuocoLand De-risked Growth While Sales Slipped In 1H FY2026

Introduction In the current real estate climate, market sentiment often fluctuates between cautious optimism and...
SGX-LISTED COMPANIES

CDL Hospitality Trusts Reveal Major Hotel Makeovers In FY2025

Beyond the Hotel Suite: 4 Surprising Truths About the Future of Hospitality Investing In the...
SGX-LISTED COMPANIES

How MPACT Defies Global Headwinds – Q3 FY25/26

The Singapore Anchor: How MPACT’s Tactical Retreat and Domestic Strength Defied Global Translational Drag In...
SGX-LISTED COMPANIES

How CapitaLand Ascott Trust Is Recalibrating Global Lodging In FY2025

The Yield Alchemist Introduction: The New Era of Global Lodging In a global macro environment where...
SGX-LISTED COMPANIES

Starhill Global REIT Keeps Returns Totally Stable In 1H FY25/26

Beyond the Shop Front: 5 Insightful Takeaways from Starhill Global REIT’s Latest Results In a...
SGX-LISTED COMPANIES

Micro-Mechanics 14-Quarter High – Q2 FY2026 & 1H FY2026

The Cash Fortress: Inside Micro-Mechanics’ 1H FY2026 Surge Introduction: The Invisible Engine of the Digital...
SGX-LISTED COMPANIES

The Secret To Lonza’s Massive FY2025 Growth

5 Key Takeaways from Lonza's Blockbuster 2025 Report Takeaway 1: Record-Breaking Growth That Beat Expectations The...
SGX-LISTED COMPANIES

Mapletree Industrial’s Q3 FY25/26 Shrink To Sprint Strategy

The Data Centre Power Play: 5 Strategic Takeaways from Mapletree Industrial Trust’s Pivot In a...
SGX-LISTED COMPANIES

From Superfoods To Senior Care – Autagco Q1 FY2026

The High-Stakes Gamble of a Singapore Mainstay Introduction: The "Pivot or Perish" Reality In the unforgiving...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...